Tage Honoré

Tage Honoré is an accomplished professional with extensive experience in the biotechnology and pharmaceutical sectors. Since November 2004, Tage has served as President of Aestus Partners LLC, a business advisory firm focused on life sciences, advising over fifty clients in research and innovation. Current roles include Board Member at Vanda Pharmaceuticals, Chairman of the Scientific Advisory Board at Neuropathix, and Head of Pharmaceutical Development at Avicenna Biosciences. Previous positions include Vice President of Development at Alterna Therapeutics and CEO of Mitochondria in Motion. Education includes a Doctor of Philosophy (PhD) in Medicinal Chemistry from the Faculty of Pharmaceutical Sciences, University of Copenhagen.